Browsing WoS İndeksli Yayınlar Koleksiyonu by Department "AFSÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları Ana Bilim Dalı"
Now showing items 1-7 of 7
-
Awareness of Hepatitis B Virus Reactivation Among Physicians Administering Immunosuppressive Treatment and Related Clinical Practices
(Aves, 2019)Objective: This study aimed to evaluate the awareness and knowledge levels of all physicians administering immunosuppressive treatment concerning hepatitis B virus (HBV) reactivation, and draw attention to the importance ... -
COVID-19: Hastalığı Artıran Risk Faktörleri ve Skorlama
(AVES Yayıncılık, 2021)Şiddetli akut solunum sendromu virusu (SARS-CoV-2)’nun neden olduğu koronavirus hastalığı 2019 (COVID-19), 11 Mart 2020’de Dünya Sağlık Örgütü tarafından pandemi ilan edildikten sonra, kısa sürede büyük bir küresel ... -
Evaluation of Healthcare Professionals in Contact with Patients Diagnosed with COVID-19 Detected Outside of the Pandemic Service in our Hospital [Hastanemizde Pandemi Servisi Dışında Saptanan COVID-19 Tanısı Alan Hastalarla Temaslı Sağlık Çalışanlarının Değerlendirilmesi]
(NLM (Medline), 2021)The "Coronavirus Disease 19 (COVID-19)" caused by "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)" is still active all over the world as a pandemia. It is reported that at least 7000 health care workers (HCW) ... -
Hemodiyaliz Uygulanan Kronik Hepatit C Hastalarında Ombitasvir/Paritaprevir/ Ritonavir+Dasabuvir Tedavi Sonuçları
(Bilimsel Tıp Yayınevi, 2021)Introduction: Hepatitis C virus (HCV) infection is common in patients with end-stage renal disease who need hemodialysis or peritoneal dialysis. HCV infection increases the risk of liver-related and all-cause mortality in ... -
Hepatosteatozun Entekavir ve Tenofovir Tedavilerinde Virolojik Yanıta Etkisi
(Aves, 2019)Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine ... -
Pandemi Sürecinde Kronik Hepatit C
(AVES Yayıncılık, 2021)Şiddetli akut solunum sendromu virusu (SARS-CoV-2)’nun neden olduğu koronavirus hastalığı 2019 (COVID-19), dünyayı etkilemiş, önemli morbidite ve mortalite nedeni olmuştur. COVID-19, esas olarak pulmoner belirtilerle ortaya ... -
Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
(AVES Yayıncılık, 2021)Background: In this study, we aimed to investigate the efficacy and safety of sofosbuvir-based therapies in the treatment of chronic hepatitis C in real-world clinical practice. Methods: Data from patients with chronic ...
